GB0230202A
GB0230202D0
(en)
|
2002-12-27 |
2002-12-27 |
Ligand
|
PCT/GB2003/002804
WO2004003019A2
(en)
|
2002-06-28 |
2003-06-30 |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
EP03738294A
EP1517921B1
(en)
|
2002-06-28 |
2003-06-30 |
Dual specific ligands with increased serum half-life
|
PT03738294T
PT1517921E
(en)
|
2002-06-28 |
2003-06-30 |
DIFFERENTLY SPECIFIED LIGANDS WITH SEMI-LIFE IN THE INCREASED SERUM
|
JP2004516979A
JP2006512895A
(en)
|
2002-06-28 |
2003-06-30 |
Ligand
|
DE60305919T
DE60305919T2
(en)
|
2002-06-28 |
2003-06-30 |
DUAL SPECIFIC LIGANDS WITH INCREASED HALF TIME
|
EP09158112A
EP2135879A3
(en)
|
2002-06-28 |
2003-06-30 |
Ligand
|
CNA038204584A
CN1678634A
(en)
|
2002-06-28 |
2003-06-30 |
Immunoglobulin single variable antigen combination area and its opposite constituent
|
ES03738294T
ES2263984T3
(en)
|
2002-06-28 |
2003-06-30 |
DOUBLE-SPECIFIC LINKS WITH AN INCREASED SERIOUS MIDDLE LIFE.
|
SI200330414T
SI1517921T1
(en)
|
2002-06-28 |
2003-06-30 |
Dual specific ligands with increased serum half-life
|
DK03738294T
DK1517921T3
(en)
|
2002-06-28 |
2003-06-30 |
Immunoglobulin single variable antigen binding domains and double specific constructs thereof
|
EP10179045A
EP2366718A3
(en)
|
2002-06-28 |
2003-06-30 |
Ligand
|
AT03738294T
ATE328906T1
(en)
|
2002-06-28 |
2003-06-30 |
DUAL-SPECIFIC LIGANDS WITH INCREASED HALF-LIFE
|
CA002492092A
CA2492092A1
(en)
|
2002-06-28 |
2003-06-30 |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
AU2003244817A
AU2003244817B2
(en)
|
2002-06-28 |
2003-06-30 |
Antigen-binding immunoglobulin single variable domains and dual-specific constructs
|
EP05076402A
EP1600459A3
(en)
|
2002-06-28 |
2003-06-30 |
Ligand
|
JP2005509717A
JP2006523090A
(en)
|
2002-12-27 |
2003-12-24 |
Bispecific single domain antibody specific for ligand and for ligand receptor
|
CA002511910A
CA2511910A1
(en)
|
2002-12-27 |
2003-12-24 |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
AU2003290330A
AU2003290330A1
(en)
|
2002-12-27 |
2003-12-24 |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
EP03782689A
EP1578801A2
(en)
|
2002-12-27 |
2003-12-24 |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
PCT/GB2003/005646
WO2004058821A2
(en)
|
2002-12-27 |
2003-12-24 |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
CN 200380109315
CN1745102A
(en)
|
2002-12-27 |
2003-12-24 |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
US10/925,366
US20050271663A1
(en)
|
2001-06-28 |
2004-08-24 |
Compositions and methods for treating inflammatory disorders
|
US10/985,847
US20060002935A1
(en)
|
2002-06-28 |
2004-11-10 |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
US11/023,959
US20060106203A1
(en)
|
2002-06-28 |
2004-12-28 |
Ligand
|
HK05103582A
HK1070081A1
(en)
|
2002-06-28 |
2005-01-01 |
Dual specific ligands with increased serum half-life
|
GBGB0501752.0A
GB0501752D0
(en)
|
2002-06-28 |
2005-01-27 |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
US11/098,758
US20060073141A1
(en)
|
2001-06-28 |
2005-04-04 |
Compositions and methods for treating inflammatory disorders
|
US11/141,661
US20060257406A1
(en)
|
2002-12-27 |
2005-05-31 |
Ligand
|
US11/217,919
US20060063921A1
(en)
|
2002-06-28 |
2005-09-01 |
Ligand
|
US11/664,542
US20080008713A1
(en)
|
2002-06-28 |
2005-10-07 |
Single domain antibodies against tnfr1 and methods of use therefor
|
MX2007005650A
MX2007005650A
(en)
|
2002-12-27 |
2005-11-10 |
Ligands that enhance endogenous compounds.
|
US11/667,393
US20070298041A1
(en)
|
2002-06-28 |
2005-11-10 |
Ligands That Enhance Endogenous Compounds
|
US11/338,863
US20070104710A1
(en)
|
2002-06-28 |
2006-01-24 |
Ligand that has binding specificity for IL-4 and/or IL-13
|
US11/501,522
US20070093651A1
(en)
|
2001-06-28 |
2006-08-08 |
Ligand
|
US11/501,546
US20100234570A1
(en)
|
2001-06-28 |
2006-08-08 |
Ligand
|
CY20061101247T
CY1105191T1
(en)
|
2002-06-28 |
2006-09-04 |
DUAL SPECIFICATION CONNECTORS WITH INCREASED HALF-LIFE
|
ZA200610474A
ZA200610474B
(en)
|
2002-12-27 |
2006-12-13 |
Compositions and methods for treating inflammatory disorders
|
US11/704,832
US9321832B2
(en)
|
2002-06-28 |
2007-02-08 |
Ligand
|
IL183027A
IL183027A0
(en)
|
2002-06-28 |
2007-05-07 |
Ligands that enhance endogenous compounds
|
ZA200703755A
ZA200703755B
(en)
|
2002-12-27 |
2007-05-09 |
Ligands that enhance endogenous compounds
|
US11/981,821
US20100081792A1
(en)
|
2001-06-28 |
2007-10-31 |
Ligand
|
US12/006,933
US20080241166A1
(en)
|
2002-06-28 |
2008-01-07 |
Ligands that bind a receptor
|
US12/150,567
US20080233130A1
(en)
|
2002-06-28 |
2008-04-29 |
Ligand that has binding specificity for IL-4 and/or IL-13
|
US12/150,487
US20080233129A1
(en)
|
2002-06-28 |
2008-04-29 |
Ligand that has binding specificity for IL-4 and/or lL-13
|
US12/409,617
US20090258012A1
(en)
|
2001-06-28 |
2009-03-24 |
Compositions and methods for treating inflammatory disorders
|
JP2011005778A
JP2011125342A
(en)
|
2002-06-28 |
2011-01-14 |
Ligand
|
US13/111,516
US20110223168A1
(en)
|
2002-12-27 |
2011-05-19 |
Ligand that has binding specificity for il-4 and/or il-13
|
US13/181,834
US9028822B2
(en)
|
2002-06-28 |
2011-07-13 |
Antagonists against TNFR1 and methods of use therefor
|
US13/733,675
US20130216538A1
(en)
|
2002-12-27 |
2013-01-03 |
Compositions and Methods for Treating Inflammatory Disorders
|
US14/173,204
US20150087813A1
(en)
|
2001-06-28 |
2014-02-05 |
Ligand
|
US14/924,971
US20170145080A1
(en)
|
2002-12-27 |
2015-10-28 |
Ligand
|